Novartis Animal Health US Inc. | Novartis | Iowa | state | 2004 | $191,891 | | training reimbursement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2007 | $49,130 | | training reimbursement |
Abraxis BioScience, LLC | Bristol-Myers Squibb | Iowa | state | 2009 | $116,970 | | training reimbursement |
Abraxis BioScience, LLC | Bristol-Myers Squibb | Iowa | state | 2010 | $158,808 | | training reimbursement |
BioProtection Systems Corporation | Lumos Pharma | Iowa | state | 2007 | $71,101 | | training reimbursement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2011 | $55,629 | | training reimbursement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2008 | $57,716 | | training reimbursement |
Bausch & Lomb | Bausch Health | Florida | state | 2010 | $50,000 | | training reimbursement |
Bausch & Lomb | Bausch Health | Florida | state | 2012 | $47,493 | | training reimbursement |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | Louisiana | state | 2010 | undisclosed | | training reimbursement |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | Louisiana | state | 2011 | undisclosed | | training reimbursement |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $150,000 | | tax credit/rebate |
Sanofi-Aventis | Sanofi | Massachusetts | state | 2011 | $2,450,000 | | tax credit/rebate |
Shire HGT, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2011 | $5,855,368 | | tax credit/rebate |
Shire HGT, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2011 | $3,500,000 | | tax credit/rebate |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,152,515 | | tax credit/rebate |
Foundation Medicine Inc. | Roche | Massachusetts | state | 2011 | $78,777 | | tax credit/rebate |
Ironwood Pharmaceuticals, Inc | Ironwood Pharmaceuticals | Massachusetts | state | 2011 | $996,605 | | tax credit/rebate |
Lightlab Imaging, Inc | Abbott Laboratories | Massachusetts | state | 2011 | $75,148 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $1,196,763 | | tax credit/rebate |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,271,658 | | tax credit/rebate |
Anika Therapeutics, Inc. | Anika Therapeutics | Massachusetts | state | 2011 | $30,041 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | Massachusetts | state | 2011 | $7,623 | | tax credit/rebate |
Codman and Shurtleff, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $66,093 | | tax credit/rebate |
Depuy Mitek, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $20,717 | | tax credit/rebate |
Depuy Spine, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $85,255 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Tennessee | state | 2012 | $14,400 | | training reimbursement |
CSL Plasma, Inc. | CSL Limited | Arizona | state | 2010 | undisclosed | | enterprise zone |
CSL Plasma, Inc. | CSL Limited | Arizona | state | 2010 | undisclosed | | enterprise zone |
MILLIPORE CORPORATION | Merck KGaA (EMD) | California | state | 2011 | $59,646 | | training reimbursement |
GILEAD SCIENCES, INC. | Gilead Sciences | California | state | 2011 | $190,995 | | training reimbursement |
IMPAX LABORATORIES, INC. | Amneal Pharmaceuticals | California | state | 2011 | $195,440 | | training reimbursement |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2011 | $209,316 | | training reimbursement |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $3,239,000 | | grant |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $1,944,528 | | tax credit/rebate |
SIGMA-ALDRICH CO. LLC | Merck KGaA (EMD) | Missouri | state | 2011 | $100,000 | | tax credit/rebate |
GlaxoSmithKline Biologicals | GlaxoSmithKline | Montana | state | 2011 | $240,000 | | grant/loan hybrid program |
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $85,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $55,000 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2011 | $15,000 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $252,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $18,000 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $134,250 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $15,000 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $649,364 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2011 | $743,297 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $344,981 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $2,774,342 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $6,896,304 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $214,710 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $21,024 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2011 | $129,618 | | property tax abatement |
Daiichi Sankyo, Inc. | Daiichi Sankyo | Pennsylvania | state | | $246,000 | | tax credit/rebate |
Daiichi Sankyo, Inc. | Daiichi Sankyo | Pennsylvania | state | | $350,000 | | grant |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | | $100,000 | | grant |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2011 | $19,590,893 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Pennsylvania | state | 2011 | $5,195,497 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Pennsylvania | state | 2011 | $2,114,575 | | tax credit/rebate |
SmithKline Beecham Corporation DBA GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | 2011 | $951,581 | | tax credit/rebate |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $740,231 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $566,948 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2011 | $481,489 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2011 | $437,312 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2011 | $277,248 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2011 | $225,955 | | tax credit/rebate |
NuPathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $161,044 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2011 | $159,381 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2011 | $141,093 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2011 | $118,136 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2011 | $93,540 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2011 | $81,973 | | tax credit/rebate |
CSL Behring, LLC. | CSL Limited | Pennsylvania | state | 2011 | $70,263 | | tax credit/rebate |
Ventana USA, LLP | Roche | Pennsylvania | state | 2011 | $55,480 | | tax credit/rebate |
Supelco, Inc. | Merck KGaA (EMD) | Pennsylvania | state | 2011 | $18,828 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $10,746 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | Pennsylvania | state | 2011 | $5,401 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | Pennsylvania | state | 2011 | $4,956 | | tax credit/rebate |
Mylan Technologies, Inc | Viatris | Vermont | state | 2012 | $4,228,373 | | grant |
Mylan Technologies | Viatris | Vermont | state | 2011 | $41,813 | | training reimbursement |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $131,488 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2010 | $105,430 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $95,385 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2010 | $72,840 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2010 | $56,975 | | tax credit/rebate |
PROFIBRIX INC | Novartis | Washington | state | 2010 | $23,490 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2010 | $8,801 | | tax credit/rebate |
C3I, Inc. | Merck | New Hampshire | state | 2012 | $9,105 | | training reimbursement |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
FOREST LABORATORIES, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
FOREST RESEARCH INSTITUTE, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
OPTIMER PHARMACEUTICALS, INC. | Merck | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
AMNEAL PHARMACEUTICALS LLC | Amneal Pharmaceuticals | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
Amgen USA, Inc. | Amgen | North Carolina | state | 2011 | $2,572 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2011 | $3,743 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2011 | $6,773 | | tax credit/rebate |
Mallinckrodt, Inc. (DE) | Mallinckrodt | North Carolina | state | 2011 | $8,686 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2011 | $9,731 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2011 | $20,940 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2011 | $21,304 | | tax credit/rebate |
Serenex, Inc. | Pfizer | North Carolina | state | 2011 | $21,743 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2011 | $31,277 | | tax credit/rebate |